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ene silencing is the sine qua non of differentiation, and 
reversal of gene silencing paves the way for a cell to 
adopt a new fate. In a new study, Francesca De Santa, 
Giaocchino Natoli, and colleagues (European Institute of On-
cology, Milan, Italy) identify a desilencing protein that might 
let cells fi  nd new fates during infl  ammation.
“Under conditions of chronic infl  ammation, tissues tend to 
show altered differentiation,” Natoli says. Chronic gastritis, 
for instance, can lead to the formation of intestinal cells within 
the stomach lining. And in a rejected kidney transplant, host 
macrophages turn into endothelial cells, creating new 
lymphatic vessels.
For macrophages to adopt new fates, a lysine in histone H3 
must fi  rst be demethylated to relieve the silencing of cell fate 
determinants. One group of enzymes that removes methyl groups 
is the JmjC domain proteins, which includes JmjD3, whose exact 
function has been unclear. In the new work, the authors discovered 
that JmjD3 was up-regulated during infl  ammation and that it 
demethylated cell fate genes.
Jmdj3’s target genes included late HoxA genes, which are 
powerful determinants of cell fate. Additionally, knock down 
of Jmdj3 inhibited the demethylation of bone morphogenetic 
protein 2, thus preventing its normal inflammation-induced 
increase.
The existence of a system to erase controls on terminal 
differentiation may seem counterintuitive at fi  rst, but “it makes 
a lot of biological sense,” says Natoli. In situations in which 
tissue regeneration is needed, and local stem cells are exhausted, 
there may be a need to recruit other cell types. New lymphatic 
vessels, for instance, may be needed to increase the fl  ow of 
debris out of an injured and infl  amed area, Natoli suggests. 
“Infl  ammation loosens control over differentiation, and Jmdj3 
may be the molecular link between these processes.”
Reference: De Santa, F., et al. 2007. Cell. 130:1083–1094. 
Jmdj3 (red) removes lysine methyl groups (green) from chromatin and 
allows macrophages to become new cell types.
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ed blood cells need their 
space, suggest results from 
Merav Socolovsky (Univer-
sity of Massachusetts Medical 
School), Andre Levchenko 
(Johns Hopkins University), 
and colleagues. Fetal develop-
ing red blood cells, they 
show, might just kill some of 
the brethren they are close 
enough to touch.
During early embryo-
genesis, red blood cells 
need to be produced at a 
high rate to keep the embryo 
well oxygenated. Their precursors 
therefore start out growing ten times 
faster than the fetus as a whole. This fecun-
dity must be shut down at the right time to 
prevent overgrowth. To determine how growth 
is limited, the group measured cell 
numbers at each stage of RBC devel-
opment and constructed a mathematical 
model to ﬁ   t the numerical data. The 
model predicted the existence of negative auto-
regulation as a result of physical contact between 
immature red cell progenitors.
Contact-initiated death is well-suited to the 
FAS system, in which contact between cells express-
ing FAS and those expressing its ligand, FASL, 
results in suicide in the FAS cell. With this in mind, 
the authors found that both FAS and FASL were 
expressed shortly after red blood cell maturation 
began, at the same time the model predicted action 
by the inhibitory component. When FAS/FASL-
expressing cell numbers are low, they rarely inter-
act, and death remains rare. As their numbers 
grow, however, their rate of interaction grows geo-
metrically. It’s then, says Socolovsky, that “the 
brakes come on to prevent overgrowth.”
The regulatory system not only keeps the 
number of cells from growing too large of its own 
accord, it also protects the system from external 
perturbations. If a trauma, for example, depletes 
the body of red blood cells, their new-found 
personal space will allow for replenishment.
Reference: Socolovsky, M., et al. 2007. PLoS Biol. 
doi:10.1371/journal.pbio.0050252.
Red blood cells have a killer touch
Red blood cells developing around 
a macrophage (center) are close 
enough to touch—and sometimes 
kill—each other.
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